MHDBAY

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMHDBAY
Drug Alias Namelong-acting recombinant PACAP-derived peptide (Jinan University)MHDBAY
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVasoactive intestinal polypeptide receptor 2 agonistsInsulin release stimulants
TargetsVasoactive intestinal polypeptide receptor 2Insulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesJinan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJinan University
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A